Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 347.604 million compared to CNY 259.428 million a year ago. Operating income was CNY 167.664 million compared to CNY 121.641 million a year ago. Net income was CNY 147.316 million compared to CNY 107.055 million a year ago. Basic earnings per share from continuing operations was CNY 0.2814 compared to CNY 0.2045 a year ago.